Global heparin market to be valued at $15b by 2030

One key driver is the innovation in drug delivery systems and formulations.

The global heparin market is expected to reach $15b by 2030 amidst the rising incidence of cardiovascular diseases and an ageing population, said DelveInsight.

One key driver for the sector’s growth is the innovation in drug delivery systems and formulations, including low molecular weight heparin (LMWH) developments to improve treatment efficacy and safety.

“Additionally, the development of more efficient manufacturing processes, such as recombinant heparins, has helped meet the growing demand and reduce dependency on animal sources,” the report said.

Meanwhile, strict production regulations are expected to impact market dynamics by increasing costs and creating barriers to entry for new manufacturers.

Economic pressures and healthcare cost-control measures may limit the sector’s growth, whilst competition from alternative anticoagulants and biosimilars is expected to impact the market by providing additional treatment options.

Follow the link for more news on

report

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit